Brief: Iroquois Capital Delivers Open Letter To Pharmacyte Biotech Board Of Directors
11/05/2022 14:16
May 11 (Reuters) - Iroquois Capital Management LLC:
* IROQUOIS CAPITAL DELIVERS OPEN LETTER TO PHARMACYTE
BIOTECH
BOARD OF DIRECTORS
Source text for Eikon: ID:nPn1lQg1ta
Further company coverage: PMCB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer